The Capsule Endoscopy Findings in S-1-induced Enteritis with Severe Diarrhea during Adjuvant Chemotherapy for Gastric Cancer (with Video)

Intern Med. 2018 Feb 1;57(3):343-344. doi: 10.2169/internalmedicine.9519-17. Epub 2017 Nov 1.

Abstract

Although S-1 chemotherapy is used widely as postoperative adjuvant chemotherapy for gastric cancer, some patients experience diarrhea during treatment. The patient was a 39-year-old woman who underwent distal gastrectomy for gastric cancer and who had started S-1 chemotherapy as postoperative adjuvant chemotherapy 1 week before her presentation. She experienced severe diarrhea immediately after starting the course of S-1 tablets. Capsule endoscopy revealed severe S-1-induced enteritis with extensive mucosal injury in the ileum and red intestinal fluid due to the oozing of blood in the ileum. After reducing the dosage of S-1, her diarrhea became milder, and she was able to continue S-1 chemotherapy.

Keywords: S-1-induced enteritis; chemotherapy; diarrhea; endoscopic findings.

Publication types

  • Case Reports
  • Video-Audio Media

MeSH terms

  • Adult
  • Antimetabolites, Antineoplastic / adverse effects*
  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Capsule Endoscopy*
  • Chemotherapy, Adjuvant
  • Diarrhea / chemically induced*
  • Diarrhea / diagnostic imaging
  • Drug Combinations
  • Enteritis / chemically induced*
  • Enteritis / diagnostic imaging
  • Female
  • Gastrectomy
  • Humans
  • Oxonic Acid / adverse effects*
  • Oxonic Acid / therapeutic use
  • Severity of Illness Index
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / surgery
  • Tegafur / adverse effects*
  • Tegafur / therapeutic use

Substances

  • Antimetabolites, Antineoplastic
  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid